Compounders Research Compare

LENSAR Inc(LNSR)

Medical - Devices · Orlando, FL

$6.73+0.06 (+0.90%)

Delayed quote: Oct 6, 2026, 11:04 AM EDT

About LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Orlando, FL

150 employees

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Nicholas T. Curtis

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:07:25.441Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:07:25.441Z.

Quote observation: 2026-10-06T15:04:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 82,655,040
Total debt · period ending 2026-06-30: 2,381,000
Cash · period ending 2026-06-30: 13,565,000
TTM operating EBITDA · period ending 2026-06-30: -4,434,000

FMP input reference: 4b39d0c73cbdfa69f0b7c8f40e573a317b01c7cc2fd28b7d8d8bae27d2fbb310

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LNSR EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

LNSR Competitors' EV/EBITDA Ratio

LENSAR Inc

Current

Market Cap

$82.66M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Nutriband Inc.

Market Cap

$82.66M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Acrivon Therapeutics, Inc. Common Stock

Market Cap

$82.69M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MediciNova, Inc.

Market Cap

$83.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Oncology, Inc.

Market Cap

$81.02M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Atara Biotherapeutics, Inc.

Market Cap

$83.43M

EV/EBITDA Ratio

N/A

TTM Avg

8.06x

3Y Avg

8.06x

5Y Avg

8.06x

Cognition Therapeutics, Inc.

Market Cap

$84.58M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Humacyte, Inc.

Market Cap

$85.18M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulmonx Corporation

Market Cap

$80.12M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cardiff Oncology, Inc.

Market Cap

$85.55M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
LENSAR Inc (LNSR)	$82.66M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$82.66M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$82.69M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$83.18M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$81.02M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$83.43M	N/A	8.06x	8.06x	8.06x
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.58M	N/A	N/A	N/A	N/A
Humacyte, Inc. (HUMA)vs ›	$85.18M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$80.12M	N/A	N/A	N/A	N/A
Cardiff Oncology, Inc. (CRDF)vs ›	$85.55M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics